These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24864346)

  • 21. [Meningococcal meningitis epidemics. African aspects].
    Martet G; Merlin M; Debonne JM
    Med Trop (Mars); 1994; 54(4):355-60. PubMed ID: 7746131
    [No Abstract]   [Full Text] [Related]  

  • 22. Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt.
    Greenwood BM; Aseffa A; Caugant DA; Diallo K; Kristiansen PA; Maiden MCJ; Stuart JM; Trotter CL
    Trop Med Int Health; 2019 Feb; 24(2):143-154. PubMed ID: 30461138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal conjugate vaccines.
    Zimmer SM; Stephens DS
    Expert Opin Pharmacother; 2004 Apr; 5(4):855-63. PubMed ID: 15102568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine.
    MenAfriCar consortium
    J Infect Dis; 2015 Oct; 212(8):1298-307. PubMed ID: 25858956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new conjugate meningococcal vaccine (Menveo).
    Med Lett Drugs Ther; 2010 Jul; 52(1343):59-60. PubMed ID: 20651639
    [No Abstract]   [Full Text] [Related]  

  • 26. Control of meningitis outbreaks in the African meningitis belt.
    Obaro SK; Habib AG
    Lancet Infect Dis; 2016 Apr; 16(4):400-2. PubMed ID: 27036337
    [No Abstract]   [Full Text] [Related]  

  • 27. 2010 FIFA world cup South Africa: travel health issues and new options for protection against meningococcal disease.
    Zuckerman JN; Bröker M; Worth C
    Travel Med Infect Dis; 2010 Mar; 8(2):68-73. PubMed ID: 20478511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningitis control in countries of the African meningitis belt, 2015.
    Wkly Epidemiol Rec; 2016 Apr; 91(16):209-16. PubMed ID: 27108455
    [No Abstract]   [Full Text] [Related]  

  • 29. The burden of meningococcal meningitis in the African Meningitis Belt, from 2009 to 2014: a trend analysis.
    Jaca A; Wiyeh AB; Sambala EZ; Wiysonge CS
    Pan Afr Med J; 2021; 39():57. PubMed ID: 34422180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa.
    Woods CW; Armstrong G; Sackey SO; Tetteh C; Bugri S; Perkins BA; Rosenstein NE
    Lancet; 2000 Jan; 355(9197):30-3. PubMed ID: 10615888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
    Manigart O; Trotter C; Findlow H; Assefa A; Mihret W; Moti Demisse T; Yeshitela B; Osei I; Hodgson A; Quaye SL; Sow S; Coulibaly M; Diallo K; Traore A; Collard JM; Moustapha Boukary R; Djermakoye O; Mahamane AE; Jusot JF; Sokhna C; Alavo S; Doucoure S; Ba el H; Dieng M; Diallo A; Daugla DM; Omotara B; Chandramohan D; Hassan-King M; Nascimento M; Woukeu A; Borrow R; Stuart JM; Greenwood B
    PLoS One; 2016; 11(2):e0147928. PubMed ID: 26872255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of the Norwegian Institute of Public Health to the development of vaccines against serogroup B meningococcal disease.
    Rosenqvist E; Holst J; Nøkleby H
    Vaccine; 2007 Jan; 25(6):965-6. PubMed ID: 17052822
    [No Abstract]   [Full Text] [Related]  

  • 34. A vaccine to prevent epidemic meningitis in Africa.
    Greenwood B; Stuart JM
    Lancet Infect Dis; 2012 Oct; 12(10):738-9. PubMed ID: 22818242
    [No Abstract]   [Full Text] [Related]  

  • 35. [The beginning of the end for the African meningitis belt?].
    Holen Ö
    Tidsskr Nor Laegeforen; 2011 May; 131(9-10):924. PubMed ID: 21755648
    [No Abstract]   [Full Text] [Related]  

  • 36. The Meningitis Vaccine Project.
    LaForce FM; Konde K; Viviani S; Préziosi MP
    Vaccine; 2007 Sep; 25 Suppl 1():A97-100. PubMed ID: 17521780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positive effect of meningococcal C vaccination on serogroup replacement in Neisseria meningitidis.
    Pérez-Trallero E; Vicente D; Montes M; Cisterna R
    Lancet; 2002 Sep; 360(9337):953. PubMed ID: 12354504
    [No Abstract]   [Full Text] [Related]  

  • 38. [Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine].
    Nicolas P
    Med Sante Trop; 2012; 22(3):246-58. PubMed ID: 23186941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations].
    Gendrel D
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
    Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.